Clinical Trial Update: A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating intravenous VRT106 in patients with locally advanced or metastatic solid tumors; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• VRT106

Snippet

Sponsor: Guangzhou Virotech Pharmaceutical Co., Ltd. | Conditions: Solid Tumors | Phase 1 | Status: RECRUITING